Correlation Between Regen BioPharma and Advanced Proteome

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regen BioPharma and Advanced Proteome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regen BioPharma and Advanced Proteome into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regen BioPharma and Advanced Proteome Therapeutics, you can compare the effects of market volatilities on Regen BioPharma and Advanced Proteome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regen BioPharma with a short position of Advanced Proteome. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regen BioPharma and Advanced Proteome.

Diversification Opportunities for Regen BioPharma and Advanced Proteome

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Regen and Advanced is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Regen BioPharma and Advanced Proteome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Advanced Proteome and Regen BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regen BioPharma are associated (or correlated) with Advanced Proteome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Advanced Proteome has no effect on the direction of Regen BioPharma i.e., Regen BioPharma and Advanced Proteome go up and down completely randomly.

Pair Corralation between Regen BioPharma and Advanced Proteome

If you would invest  5.20  in Regen BioPharma on December 30, 2024 and sell it today you would lose (0.09) from holding Regen BioPharma or give up 1.73% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy98.46%
ValuesDaily Returns

Regen BioPharma  vs.  Advanced Proteome Therapeutics

 Performance 
       Timeline  
Regen BioPharma 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.
Advanced Proteome 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Advanced Proteome Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Advanced Proteome is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Regen BioPharma and Advanced Proteome Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regen BioPharma and Advanced Proteome

The main advantage of trading using opposite Regen BioPharma and Advanced Proteome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regen BioPharma position performs unexpectedly, Advanced Proteome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Advanced Proteome will offset losses from the drop in Advanced Proteome's long position.
The idea behind Regen BioPharma and Advanced Proteome Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules